You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

neuroendocrine prostate cancer (NEPC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • +3 more
  • (no location specified)
Dec 7, 2022

Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston

Not yet recruiting
  • Advanced Prostate Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Sep 25, 2023

Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic

Not yet recruiting
  • Metastatic Malignant Neoplasm in the Viscera
  • +4 more
  • Lutetium Lu 177 Dotatate
  • (no location specified)
Jan 25, 2023

Prostate Cancer Metastatic, Neuroendocrine Tumors Trial in Atlanta, Ann Arbor (Pembrolizumab, Lenvatinib)

Recruiting
  • Prostate Cancer Metastatic
  • Neuroendocrine Tumors
  • Duarte, California
  • +2 more
Jan 18, 2023

Prostate Cancer Trial in Durham (Copper, Disulfiram, Copper gluconate)

Terminated
  • Prostate Cancer
  • Durham, North Carolina
    Duke University Medical Center
Sep 13, 2021

Tumor Recurrence Following Radiotherapy

Recruiting
  • Prostate Cancer
    • Rochester, Minnesota
      Mayo Clinic
    Jan 20, 2023

    Small Cell Neuroendocrine Carcinoma, Prostate Cancer, Small Cell Carcinoma Trial in San Francisco (Apalutamide, Cetrelimab)

    Recruiting
    • Small Cell Neuroendocrine Carcinoma
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Mar 21, 2022

    Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

    Not yet recruiting
    • Prostate Carcinoma
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 17, 2023

    Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen

    Recruiting
    • Castration-Resistant Prostate Carcinoma
    • +7 more
    • Biopsy
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Prostate Cancer Trial in Durham (Avelumab)

    Completed
    Has Results
    • Prostate Cancer
    • Durham, North Carolina
      Duke University Medical Center
    Feb 12, 2021

    Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle

    Active, not recruiting
    • Castration-Sensitive Prostate Carcinoma
    • +7 more
    • Antiandrogen Therapy
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 8, 2022

    Metastatic Prostate Cancer, Neuroendocrine Prostate Cancer Trial in Detroit, New York, Lancaster (ORIC-944)

    Recruiting
    • Metastatic Prostate Cancer
    • Neuroendocrine Prostate Cancer
    • Detroit, Michigan
    • +2 more
    Sep 19, 2022

    Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma

    Recruiting
    • Bladder Small Cell Neuroendocrine Carcinoma
    • +16 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Mar 23, 2022

    Neuroendocrine Prostate Cancer Trial in Worldwide (Tarlatamab)

    Recruiting
    • Neuroendocrine Prostate Cancer
    • Phoenix, Arizona
    • +19 more
    Aug 11, 2022

    Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in Atlanta (CT

    Active, not recruiting
    • Castration-Resistant Prostate Carcinoma
    • +2 more
    • CT (Computed Tomography)
    • +2 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Mar 3, 2022

    Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in United States (JBI-802)

    Recruiting
    • Locally Advanced Solid Tumor
    • Metastatic Solid Tumor
    • Denver, Colorado
    • +3 more
    Aug 19, 2022

    Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health

    Not yet recruiting
    • Advanced Malignant Solid Neoplasm
    • +18 more
    • Clinical Encounter
    • +3 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Jul 24, 2023

    Neuroendocrine Tumors, Prostate Cancer Trial in Salt Lake City (Single-Tracer FDG PET/CT Exam, Single-Tracer Cu64-DOTATATE

    Recruiting
    • Neuroendocrine Tumors
    • Prostate Cancer
    • Single-Tracer FDG PET/CT Exam
    • +3 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Dec 27, 2022

    Anal Squamous Cell Carcinoma, Colorectal Tumors, Soft Tissue Sarcoma Trial (Regorafenib in combination with Tislelizumab)

    Not yet recruiting
    • Anal Squamous Cell Carcinoma
    • +7 more
    • Regorafenib in combination with Tislelizumab
    • (no location specified)
    Oct 12, 2022

    Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston

    Recruiting
    • Aggressive Variant Prostate Carcinoma
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 10, 2022

    Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate

    Suspended
    • Castration-Resistant Prostate Carcinoma
    • +4 more
    • Abiraterone Acetate
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 27, 2022

    Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)

    Recruiting
    • Genitourinary Cancer
    • +7 more
    • La Jolla, California
    • +5 more
    Jul 5, 2022

    Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)

    Not yet recruiting
    • Medullary Thyroid Cancer
    • +3 more
    • Groningen, Netherlands
      University Medical Centre Groningen
    Sep 8, 2022

    Pancreatic Ductal Adenocarcinoma (PDAC), Squamous Cell Carcinoma of Head and Neck, Colorectal Cancer Trial in Omaha

    Recruiting
    • Pancreatic Ductal Adenocarcinoma (PDAC)
    • +6 more
    • Omaha, Nebraska
      Urology Cancer Center/XCancer
    Nov 29, 2022

    Thyroid Cancer, Prostate Cancer, Neuroendocrine Tumors Trial in Montpellier (Biological collection)

    Recruiting
    • Thyroid Cancer
    • +2 more
    • Biological collection
    • Montpellier, France
      Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
    Nov 3, 2021